| scholarly article | Q13442814 |
| P50 | author | John M. Luk | Q42935545 |
| Irene Oi-lin Ng | Q67487913 | ||
| Wen Xue | Q76388685 | ||
| P2093 | author name string | Lars Zender | |
| Scott W Lowe | |||
| Hongyue Dai | |||
| Hsiang-fu Kung | |||
| Nikki P Lee | |||
| Chunsheng Zhang | |||
| Mao Mao | |||
| Ronnie T P Poon | |||
| Terence K Lee | |||
| Yangchao Chen | |||
| Jian Hua Wang | |||
| Vivian W Chan | |||
| Michelle Z Xu | |||
| Xiao Lin Wang | |||
| Ling Xiao Liu | |||
| P2860 | cites work | Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma | Q24300140 |
| Association of intestinal peptide transport with a protein related to the cadherin superfamily | Q24310460 | ||
| Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach | Q24633776 | ||
| LI-cadherin: a marker of gastric metaplasia and neoplasia | Q24669690 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration | Q28238880 | ||
| Liver-intestine cadherin: molecular cloning and characterization of a novel Ca(2+)-dependent cell adhesion molecule expressed in liver and intestine | Q28580345 | ||
| Modeling recurrent DNA copy number alterations in array CGH data | Q31119520 | ||
| Intestinal LI-cadherin acts as a Ca2+-dependent adhesion switch | Q33285113 | ||
| Heterotypic trans-interaction of LI- and E-cadherin and their localization in plasmalemmal microdomains | Q33323994 | ||
| Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma | Q33329606 | ||
| Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas | Q34208599 | ||
| Overexpression of LI-cadherin in gastric cancer is associated with lymph node metastasis. | Q34324655 | ||
| An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer | Q34345765 | ||
| Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma. | Q34392558 | ||
| Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma | Q34563222 | ||
| Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype | Q34619635 | ||
| Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome | Q35648684 | ||
| Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors | Q36129235 | ||
| Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. | Q36415612 | ||
| Restoration of p53 to limit tumor growth | Q37016843 | ||
| Updates on p53: modulation of p53 degradation as a therapeutic approach | Q37053528 | ||
| Murine monoclonal antibody specific for lipopolysaccharide of Salmonella serogroup A. | Q37222284 | ||
| The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer | Q38504515 | ||
| Identification of liver-intestine cadherin in hepatocellular carcinoma--a potential disease marker. | Q40615909 | ||
| A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice | Q40909623 | ||
| Establishment of cell lines from a primary hepatocellular carcinoma and its metastatis | Q42798888 | ||
| Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis | Q44503107 | ||
| Blockage of testicular connexins induced apoptosis in rat seminiferous epithelium. | Q52017854 | ||
| Unique gene structure and paralogy define the 7D-cadherin family. | Q52932220 | ||
| Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. | Q53544194 | ||
| Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer. | Q53617820 | ||
| Diagnosis and Treatment of Hepatocellular Carcinoma | Q56172242 | ||
| Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure | Q57980982 | ||
| Expression of liver-intestine cadherin and its correlation with lymph node metastasis in gastric cancer: can it predict N stage preoperatively? | Q79298383 | ||
| A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma | Q80916511 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver carcinoma | Q18557387 |
| P304 | page(s) | 1453-1463 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma | |
| P478 | volume | 50 |
| Q35766077 | 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules |
| Q30988536 | A novel melanoma-targeting peptide screened by phage display exhibits antitumor activity |
| Q35899490 | AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. |
| Q51014889 | Acid active receptor-specific peptide ligand for in vivo tumor-targeted delivery. |
| Q24306146 | An RGD motif present in cadherin 17 induces integrin activation and tumor growth |
| Q34988368 | Anti-cadherin-17 antibody modulates beta-catenin signaling and tumorigenicity of hepatocellular carcinoma |
| Q35221853 | Association between cadherin-17 expression and pathological characteristics of gastric cancer: a meta-analysis |
| Q35001647 | BILL-cadherin/cadherin-17 contributes to the survival of memory B cells |
| Q53022205 | BIRC6 promotes hepatocellular carcinogenesis: interaction of BIRC6 with p53 facilitating p53 degradation. |
| Q38179961 | Beyond E-cadherin: roles of other cadherin superfamily members in cancer |
| Q92028650 | Beyond N-Cadherin, Relevance of Cadherins 5, 6 and 17 in Cancer Progression and Metastasis |
| Q39714510 | Blockade of proliferation and migration of gastric cancer via targeting CDH17 with an artificial microRNA. |
| Q47547369 | Cadherin 17 is related to recurrence and poor prognosis of cytokeratin 19-positive hepatocellular carcinoma |
| Q89777467 | Cadherin 17 mutation associated with leaky severe combined immune deficiency is corrected by HSCT |
| Q36677718 | Cadherin-17 induces tumorigenesis and lymphatic metastasis in gastric cancer through activation of NFκB signaling pathway |
| Q39162923 | Cadherin-17 interacts with α2β1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis. |
| Q38965946 | Cancer stem cells: A product of clonal evolution? |
| Q35841111 | Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study |
| Q36420885 | Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma. |
| Q34427459 | Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model |
| Q53216791 | Correlations of fascin-1 and cadherin-17 protein expression with clinicopathologic features and prognosis of patients with gastric cancer. |
| Q39411411 | Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma |
| Q28391394 | Dickkopfs and Wnt/β-catenin signalling in liver cancer |
| Q36246766 | Effects of the miR-143/-145 microRNA cluster on the colon cancer proteome and transcriptome |
| Q37620228 | Expression of Cadherin-17 Promotes Metastasis in a Highly Bone Marrow Metastatic Murine Breast Cancer Model |
| Q91873968 | Focal Adhesion Kinase and β-Catenin Cooperate to Induce Hepatocellular Carcinoma |
| Q28740309 | Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma |
| Q28567664 | Genomic and metabolic responses to methionine-restricted and methionine-restricted, cysteine-supplemented diets in Fischer 344 rat inguinal adipose tissue, liver and quadriceps muscle |
| Q42935421 | Hepatic tight junctions: from viral entry to cancer metastasis |
| Q42718037 | Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences. |
| Q39619016 | Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. |
| Q37530742 | Inhibition of CDH17 gene expression via RNA interference reduces proliferation and apoptosis of human MKN28 gastric cancer cells |
| Q37718419 | Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma |
| Q38073099 | Involvement of liver-intestine cadherin in cancer progression |
| Q36066837 | Knockdown of liver-intestine cadherin decreases BGC823 cell invasiveness and metastasis in vivo |
| Q36774942 | LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway |
| Q53275154 | Liver-intestine cadherin expression is associated with intestinal differentiation and carcinogenesis in intraductal papillary mucinous neoplasm. |
| Q83150395 | Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma |
| Q37229396 | MicroRNA-375 targets the 3-phosphoinositide-dependent protein kinase-1 gene in pancreatic carcinoma |
| Q35092706 | Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy |
| Q38199099 | Possible roles of LI-Cadherin in the formation and maintenance of the intestinal epithelial barrier |
| Q38996944 | Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2. |
| Q39442425 | Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma. |
| Q33894207 | Prophylactic uses of integrin CD18-betaA peptide in a murine polymicrobial peritonitis model |
| Q38799520 | Protein phosphatase magnesium-dependent 1δ is a novel tumor marker and target in hepatocellular carcinoma |
| Q37977415 | Proteomic research progress in lymphatic metastases of cancers |
| Q58062853 | Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma |
| Q37857056 | Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches. |
| Q34647792 | Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling |
| Q37495777 | Targeting cadherin-17 inactivates Ras/Raf/MEK/ERK signaling and inhibits cell proliferation in gastric cancer |
| Q64289821 | Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist? |
| Q37886262 | The testicular germ cell tumour transcriptome |
| Q37915623 | Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents. |
| Q36562094 | Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome |
| Q37510658 | miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma |
| Q24595141 | microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma |
Search more.